LT1991522T - Deuterinti katecholamino dariniai ir minėtų junginių turintys vaistai - Google Patents

Deuterinti katecholamino dariniai ir minėtų junginių turintys vaistai

Info

Publication number: LT1991522T
Authority: LT; Lithuania
Prior art keywords: medicaments; compounds; catecholamine derivatives; deuterated catecholamine; deuterated
Prior art date: 2006-02-17

Application number

LTEP07703542.6T

Other languages

English (en)

Inventor

Rudolf-Giesbert Alken

Frank Schneider

Original Assignee

Ratiopharm Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-02-17

Filing date

2007-02-16

Publication date

2016-09-26

2007-02-16 Application filed by Ratiopharm Gmbh filed Critical Ratiopharm Gmbh

2016-09-26 Publication of LT1991522T publication Critical patent/LT1991522T/lt

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/001—Acyclic or carbocyclic compounds
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers

LTEP07703542.6T 2006-02-17 2007-02-16 Deuterinti katecholamino dariniai ir minėtų junginių turintys vaistai LT1991522T (lt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE102006008316		2006-02-17
PCT/EP2007/001555 WO2007093450A2 (en)	2006-02-17	2007-02-16	Deuterated catecholamine derivatives and medicaments comprising said compounds

Publications (1)

Publication Number	Publication Date
LT1991522T true LT1991522T (lt)	2016-09-26

Family

ID=38236462

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LTEP07703542.6T LT1991522T (lt)	2006-02-17	2007-02-16	Deuterinti katecholamino dariniai ir minėtų junginių turintys vaistai

Country Status (24)

Country	Link
US (2)	USRE46555E1 (lt)
EP (2)	EP3101001B1 (lt)
JP (1)	JP5248331B2 (lt)
KR (1)	KR101411422B1 (lt)
CN (1)	CN101384545B (lt)
AU (1)	AU2007214622B2 (lt)
BR (1)	BRPI0708071A8 (lt)
CA (1)	CA2642593C (lt)
CY (1)	CY1117995T1 (lt)
DK (1)	DK1991522T3 (lt)
EA (1)	EA017983B1 (lt)
ES (1)	ES2587368T3 (lt)
HR (1)	HRP20161039T1 (lt)
HU (1)	HUE028777T2 (lt)
IL (1)	IL193102A (lt)
LT (1)	LT1991522T (lt)
ME (1)	ME02508B (lt)
PL (1)	PL1991522T3 (lt)
PT (1)	PT1991522T (lt)
RS (1)	RS55142B1 (lt)
SI (1)	SI1991522T1 (lt)
UA (1)	UA97795C2 (lt)
WO (1)	WO2007093450A2 (lt)
ZA (1)	ZA200806568B (lt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7776314B2 (en)	2002-06-17	2010-08-17	Grunenthal Gmbh	Abuse-proofed dosage system
US20070048228A1 (en)	2003-08-06	2007-03-01	Elisabeth Arkenau-Maric	Abuse-proofed dosage form
RU2540470C9 (ru)	2008-06-06	2015-07-20	Фарма Ту Б Лтд.	Фармацевтические композиции для лечения болезни паркинсона
BRPI0916769A2 (pt)	2008-07-15	2017-09-26	Theracos Inc	derivados de benzilbenzeno deuterados e métodos de uso
BR112014019988A8 (pt)	2012-02-28	2017-07-11	Gruenenthal Gmbh	Forma de dosagem resistente a socamento compreendendo um composto farmacologicamente ativo e um polímero aniônico
US9550780B2 (en)	2012-09-18	2017-01-24	Auspex Pharmaceuticals, Inc.	Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
AU2013318182C1 (en)	2012-09-18	2022-01-20	Auspex Pharmaceuticals, Inc.	Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
US9763904B2 (en)	2013-02-05	2017-09-19	Teva Pharmaceuticals International Gmbh	Position-specific asymmetric deuterium enriched catecholamine derivatives and medicaments comprising said compounds
BR112015016889A8 (pt)	2013-02-05	2018-01-23	Imphar Ag	derivados de catecolamina enriquecidos com deutério em posição específica
WO2014174425A2 (en) *	2013-04-24	2014-10-30	Mahesh Kandula	Compositions and methods for the treatment of orthostasis and neurological diseases
EP3019467A4 (en) *	2013-07-08	2017-03-15	Auspex Pharmaceuticals, Inc.	Dihydroxyphenyl neurotransmitter compounds, compositions and methods
US20160303110A1 (en) *	2013-11-22	2016-10-20	Auspex Pharmaceuticals, Inc.	Methods of treating abnormal muscular activity
MX369956B (es)	2013-12-03	2019-11-27	Auspex Pharmaceuticals Inc	Metodos para preparar compuestos de benzoquinolina.
WO2015120110A2 (en)	2014-02-07	2015-08-13	Auspex Pharmaceuticals, Inc.	Novel pharmaceutical formulations
EP2918266A1 (en)	2014-03-11	2015-09-16	CDRD Berolina AB	Composition comprising a dopamine agonist and an L-DOPA derivative for treating Parkinson's disease
GB201420341D0 (en) *	2014-11-17	2014-12-31	Evolution Valves Ltd	Valve arrangement
IL305352A (en)	2015-03-06	2023-10-01	Auspex Pharmaceuticals Inc	Methods for treating abnormal movement disorders
CN106343013A (zh) *	2015-07-19	2017-01-25	中国科学院上海有机化学研究所	一种粮食储存方法
CN105360267B (zh) *	2015-10-09	2017-11-10	青岛振坤食品机械有限公司	一种全自动穿串机
JP2018530612A (ja)	2015-10-09	2018-10-18	テバ、ファーマスーティカルズ、インターナショナル、ゲゼルシャフト、ミット、ベシュレンクテル、ハフツングＴｅｖａＰｈａｒｍａｃｅｕｔｉｃａｌｓＩｎｔｅｒｎａｔｉｏｎａｌＧｍｂｈ	パーキンソン病の治療のための重水素化レボドパとカルビドパおよびオピカポンとの組合せ
CN105862897B (zh) *	2016-04-11	2018-01-16	江苏省华建建设股份有限公司	砂质泥岩地基浅基础原槽浇筑施工工法
KR20210112320A (ko) *	2018-12-06	2021-09-14	센다 바이오사이언시즈, 인크.	트리메틸아민 생산의 억제제로서의 4급 암모늄염

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3699158A (en)	1969-08-25	1972-10-17	Merck & Co Inc	Selective deuteration of tyrosine, aspartic and glutamic acids
DE2049807A1 (en)	1970-10-10	1972-04-13	Hartmeyer H	Conversion of closed cell plastics foam to - open cell structure
DE2049115C3 (de)	1970-10-06	1981-07-30	Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai, Tokyo	Verwendung von Calcium-5-butylpicolinat und/oder Calcium-5-pentylpicolinat bei der Bekämpfung des Parkinsonismus mit 3-(3,4-Dihydroxyphenyl)-L-alanin (L-Dopa)
ATE76747T1 (de) *	1986-06-10	1992-06-15	Chiesi Farma Spa	Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
IT1226902B (it)	1988-07-12	1991-02-21	Mini Ricerca Scient Tecnolog	Processo per la sintesi del levodopa
US5354885A (en) *	1992-12-24	1994-10-11	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Process for preparing ethyl ester of L-DOPA
US6221335B1 (en) *	1994-03-25	2001-04-24	Isotechnika, Inc.	Method of using deuterated calcium channel blockers
US6440710B1 (en) *	1998-12-10	2002-08-27	The Scripps Research Institute	Antibody-catalyzed deuteration, tritiation, dedeuteration or detritiation of carbonyl compounds
DK1104760T3 (da) *	1999-12-03	2003-06-30	Pfizer Prod Inc	Sulfamoylheteroarylpyrazolforbindelser som anti-inflammatoriske/analgetiske midler
DE10261808A1 (de) *	2002-12-19	2004-07-08	Turicum Drug Development Ag	Verwendung von L-DOPA, seiner Derivate und diese Verbindungen enthaltender Arzneimittel zur Prophylaxe psychotischer Erkrankungen
DE10261807A1 (de)	2002-12-19	2004-07-01	Turicum Drug Development Ag	Deuterierte Catecholaminderivate sowie diese Verbindungen enthaltende Arzneimittel

2007
- 2007-02-16 US US14/464,568 patent/USRE46555E1/en active Active
- 2007-02-16 EP EP16170031.5A patent/EP3101001B1/en active Active
- 2007-02-16 KR KR1020087022011A patent/KR101411422B1/ko active IP Right Grant
- 2007-02-16 ES ES07703542.6T patent/ES2587368T3/es active Active
- 2007-02-16 US US12/224,120 patent/US8247603B2/en not_active Ceased
- 2007-02-16 UA UAA200811184A patent/UA97795C2/uk unknown
- 2007-02-16 HU HUE07703542A patent/HUE028777T2/en unknown
- 2007-02-16 LT LTEP07703542.6T patent/LT1991522T/lt unknown
- 2007-02-16 CA CA2642593A patent/CA2642593C/en active Active
- 2007-02-16 ME MEP-2016-167A patent/ME02508B/me unknown
- 2007-02-16 EP EP07703542.6A patent/EP1991522B1/en active Active
- 2007-02-16 DK DK07703542.6T patent/DK1991522T3/en active
- 2007-02-16 PL PL07703542T patent/PL1991522T3/pl unknown
- 2007-02-16 PT PT77035426T patent/PT1991522T/pt unknown
- 2007-02-16 JP JP2008554702A patent/JP5248331B2/ja not_active Expired - Fee Related
- 2007-02-16 RS RS20160674A patent/RS55142B1/sr unknown
- 2007-02-16 AU AU2007214622A patent/AU2007214622B2/en not_active Ceased
- 2007-02-16 CN CN200780005912.6A patent/CN101384545B/zh not_active Expired - Fee Related
- 2007-02-16 BR BRPI0708071A patent/BRPI0708071A8/pt not_active Application Discontinuation
- 2007-02-16 SI SI200731819A patent/SI1991522T1/sl unknown
- 2007-02-16 WO PCT/EP2007/001555 patent/WO2007093450A2/en active Application Filing
- 2007-02-16 EA EA200801826A patent/EA017983B1/ru not_active IP Right Cessation
2008
- 2008-07-28 ZA ZA200806568A patent/ZA200806568B/xx unknown
- 2008-07-29 IL IL193102A patent/IL193102A/en active IP Right Grant
2016
- 2016-08-17 CY CY20161100808T patent/CY1117995T1/el unknown
- 2016-08-17 HR HRP20161039TT patent/HRP20161039T1/hr unknown

Also Published As

Publication number	Publication date
CY1117995T1 (el)	2017-05-17
KR20080106539A (ko)	2008-12-08
EA017983B1 (ru)	2013-04-30
ZA200806568B (en)	2009-07-29
WO2007093450A2 (en)	2007-08-23
BRPI0708071A8 (pt)	2017-12-26
JP2009526799A (ja)	2009-07-23
CN101384545A (zh)	2009-03-11
HUE028777T2 (en)	2017-01-30
CA2642593C (en)	2014-11-04
IL193102A0 (en)	2009-02-11
HRP20161039T1 (hr)	2016-11-04
EA200801826A1 (ru)	2009-02-27
SI1991522T1 (sl)	2016-10-28
PL1991522T3 (pl)	2017-07-31
US8247603B2 (en)	2012-08-21
CA2642593A1 (en)	2007-08-23
UA97795C2 (uk)	2012-03-26
WO2007093450A3 (en)	2007-09-27
USRE46555E1 (en)	2017-09-19
ES2587368T3 (es)	2016-10-24
JP5248331B2 (ja)	2013-07-31
AU2007214622A1 (en)	2007-08-23
EP1991522B1 (en)	2016-05-18
CN101384545B (zh)	2014-09-03
EP3101001B1 (en)	2020-04-01
AU2007214622B2 (en)	2012-02-23
RS55142B1 (sr)	2016-12-30
DK1991522T3 (en)	2016-08-29
EP1991522A2 (en)	2008-11-19
KR101411422B1 (ko)	2014-07-03
EP3101001A1 (en)	2016-12-07
PT1991522T (pt)	2016-08-23
US20090018191A1 (en)	2009-01-15
ME02508B (me)	2017-06-20
IL193102A (en)	2015-01-29
BRPI0708071A2 (pt)	2011-05-17

Publication	Publication Date	Title
IL193102A0 (en)	2009-02-11	Deuterated catecholamine derivatives and medicaments comprising said compounds
IL192565A0 (en)	2009-08-03	Medicament for topical use
GB0625659D0 (en)	2007-01-31	Therapeutic compounds and their use
IL194095A0 (en)	2009-08-03	Drug microparticles
ZA201000185B (en)	2011-03-30	17beta-cyano-18a-homo-19-nor-androst-4-ene derivative,use thereof and medicaments containing said derivative
IL194751A0 (en)	2009-08-03	Drugs and uses
EP2168944A4 (en)	2011-11-30	AMIN CONNECTION AND ITS PHARMACEUTICAL USE
GB0614586D0 (en)	2006-08-30	Pharmaceutical Formulation
IL196493A0 (en)	2009-11-18	Medication applicator device
EP2077262A4 (en)	2011-12-28	IMINOPYRIDINE DERIVATIVES AND THEIR USE
EP2070919A4 (en)	2010-05-05	SPIROCHINONE COMPOUND AND PHARMACEUTICAL COMPOSITION
HK1130049A1 (en)	2009-12-18	Tricyclic compound and pharmaceutical use thereof
EP2098513A4 (en)	2010-12-01	TRICYCLIC COMPOUND AND ITS PHARMACEUTICAL USE
GB0625783D0 (en)	2007-02-07	Medicament
ZA201000187B (en)	2011-03-30	17b-cyano-19-nor-androst-4-ene derivative,use thereof and medicaments containing said derivative
EP2069371A4 (en)	2010-02-10	ORGANO ARSENOXIDE COMPOUNDS AND THEIR USE
GB0615064D0 (en)	2006-09-06	Medicament
GB0613031D0 (en)	2006-08-09	Medicaments
ZA201000186B (en)	2011-03-30	17b-cyano-19-androst-4-ene derivative,use thereof and medicaments containing said derivative
EP2114404A4 (en)	2010-03-03	COMPOUND AND PHARMACEUTICAL COMPOSITION
IL191892A0 (en)	2008-12-29	2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
EP2140876A4 (en)	2011-08-03	THERAPEUTIC AGENT COMPRISING VASOHIBINE
GB0615814D0 (en)	2006-09-20	Medicament
ZA200708369B (en)	2009-08-26	Medicament
GB0614538D0 (en)	2006-08-30	Therapeutic Compounds And Their Use